Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Fellow in Hematology-Oncology, Medicine, University of Virginia 2004 - 2007
  • Resident, Medicine, University of Virginia 2001 - 2004
  • M.D., Northwestern University 2001
• 

  Previous Appointments & Affiliations

  • Assistant Professor of Medicine, Medicine, Medical Oncology, Medicine 2008 - 2020
  • Instructor, Temporary in the Department of Medicine, Medicine, Medical Oncology, Medicine 2008
• Research
• 

  External Relationships

  • Curio Science LLC
  • Dava Oncology
  • G1 Therapeutics, Inc.
  • GlaxoSmithKline
  • Omni Health Media
  • Putnam Associates LLC
  • Qessential Medical Market Research
  • QualWorld
  • Survey Healthcare Global
  • ZoomRx
  • bioTheranostics
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Beum, Paul V., David A. Mack, Andrew W. Pawluczkowycz, Margaret A. Lindorfer, and Ronald P. Taylor. “Binding of rituximab, trastuzumab, cetuximab, or mAb T101 to cancer cells promotes trogocytosis mediated by THP-1 cells and monocytes.” J Immunol 181, no. 11 (December 1, 2008): 8120–32. https://doi.org/10.4049/jimmunol.181.11.8120.
       Full Text  Link to Item

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.